Search
for
Sort by
Research 121–150 of 313
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- 1400 Low-intensity ultrasound protects human scalp hair follicles from taxane-induced toxicity
- 506 Taxane chemotherapy promotes aging of human hair follicles and their stem cells
- 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Drug-induced scarring and permanent alopecia
- Chemotherapy-induced alopecia: A novel observation
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Treatment of Chemotherapy Induced Alopecia
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- Cancer-Related Alopecia Risk and Treatment
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Alopécia Permanente Pós-Quimioterapia com Resposta Favorável ao Minoxidil Tópico
- Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Recent Literature Review
- Objective quantification of chemotherapy-induced madarosis: a pilot study of an automated computer vision pipeline for eyebrow density assessment